# P94 Real-world evidence study of dose escalation and associated costs of advanced therapies for ulcerative colitis in France and United Kingdom

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/p94-real-world-evidence-study-of-dose-escalation-and-associated-costs-of/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Tamás Treuer,Melissa N. Richards,Can Mert,Endip Dhesi,Lidia Silva,Yubo Tan,Sami Hoque |
| Citations | 0 |
| DOI | 10.1136/gutjnl-2024-bsg.176 |
| Fields | Biochemistry, Genetics and Molecular Biology,Economics, Econometrics and Finance,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4400193101 |
| Type | conference-abstract |
| Year | 2024 |

## Paper authors

- [Can Mert](https://scholariq.org/researchers/can-mert/)

## Paper primary topic

- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)

## Paper topics

- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.